Latest cell therapy News

High appetite for biotech VC cited in new report
Goldilocks treatment window could lead to cancer therapy without harmful side-effects
Philanthropy accelerates stroke trials
$270 million to accelerate med tech innovation
Australians call for equitable access to new era in fighting cancer
Immune therapy targets cells that cause leukemia relapse
Cynata Therapeutics adds new site for MEND clinical trial
Key protein facilitates regeneration of liver blood vessels
Potential new Covid immunotherapy could protect vulnerable
Programming Immune System to Supercharge Cancer Cell Therapies
Chimeric Therapeutics announces final results from Phase 1 trial of CORE NK Platform
Arovella Therapeutics closes over-subscribed share purchase plan
Treating type 1 diabetes with stem cell replacement therapy
Placental cell therapy could deliver new treatment options for liver disease
Researchers working on injection-free cell therapy for diabetes
QIMR Berghofer attracts support for potential multiple sclerosis treatment
QIMR Berghofer signs licensing, research and manufacturing deal for new cellular immunotherapy with US company Cellevolve Bio
Early intervention treatment for cerebral palsy shows promise despite sex differences
New mothers could help protect other babies’ brains
Highly Cited Researchers 16 November
Ludwig Lausanne team devises method to selectively grow tumor-targeting T cells for cancer therapy
Pelvic organ prolapse treatment attracts international award
Final ‘foundation stones’ set for future of Australian regenerative medicine
Cloaking technology: helping therapeutic cells evade your immune system
Cynata Therapeutics announces publication of new paper